Pentacel combo may be viable answer to separate vaccinations: in phase III clinical trials in U.S.(Children's Health)

CANCUN, MEXICO -- The levels of antibody titers were similar in infants immunized with a combination vaccine to those given three separate vaccines, Dr. Mark Blatter reported at the 11th International Congress on Infectious Disease.

Known as Pentacel, the combination vaccine is designed to immunize against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib). It is currently used in Canada and is in phase III trials in the United States.

Combination vaccines such as Pentacel may advance the U.S. goal of universal immunization by simplifying the immunization schedule for babies, according to Dr. Blatter of Primary Physicians Research, …